Friday, the FDA reclassified the semaglutide shortagewhich had covered multiple doses of Wegovy for obesity and Ozempic for Type 2 diabetesas "resolved" on its online drug shortage database
Zhu P, Herrington WG, Haynes R et al
Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial
And with the launch of Saxenda, they also launched a worldwide campaign lobbying for the use of these compounds for obesity therapy
The results came even faster than what I read online about people getting -- injections at medical facilities
We'll discuss your goals, review your medical history and any recent labs, evaluate appropriateness, and design a treatment plan with honest pricing